The prolonged GH elevation from DAC may increase the likelihood and duration of side effects such as water retention, joint discomfort, and potential IGF-1 overstimulation compared to pulsatile no-DAC protocols
The FDA supports development of complex generic drugs, such as GLP-1s, by funding research and informing industry through guidance as part of our ongoing efforts to increase access to needed medications, Iilun Murphy, MD, director of the Office of Generic Drugs in the FDAs Center for Drug Evaluation and Research, said in a statement
"This is going to play out over quarters, not days ask people to take a beat and let us execute." Barclays analyst Emily Field noted last week that oral Wegovy and Foundayo are going for different patient segments, with the former having "injectable-like efficacy" and the latter perhaps being viewed as more of a "starter" GLP-1
At 24 weeks, participants had lost approximately 10-11%